leverbio.com
Lever Bio aims to translate groundbreaking discoveries in immuno-oncology into next-generation cancer immunotherapies.
Company page
Who decides
No named decision-maker yet.
Careers mailbox is known
Follow
···
alkemistbio.com
ALKemist Bio is a biotech startup developing next-generation T cell therapies that target ALK-positive cancers. By reprogramming the immune system, the company aims to overcome resistance and deliver more effective, lasting treatments for solid tumors.
No named decision-maker yet.
Careers mailbox is known
Follow
···
sibyllabiotech.it
Close The story of our foundation PPI-FIT is the result of divergent thinking. It is the outcome of academic excellence at its best, where a cross-fertilizing environment allows brilliant minds to pursue disruptive ideas.
No named decision-maker yet.
Careers mailbox is known
Sep 4, 2025
New executive Sibylla Biotech Appoints CSO and VP of R&D to Advance PPI-FIT Technology and Pipeline of Folding Interference Small Molecules · YahooFinance
Oct 3, 2022
Raised a round Series A $24.8M
Follow
···
Save
Report
How many of the open roles read as an active search right now, by the liveness score every vacancy carries: board confirmation, hiring activity, room left.%d roles posted in the last 7 days.Median days from posting to closing over %1$d roles closed on this board. The market figure is the median for its main sphere, %2$s, across every company.Average stated annual pay, in USD, across the %d open roles that publish one.Truth index %s: ghost roles %d%%, stale roles %d%%, reposted %d%%, over %d open roles.